Novel specific caspase-10 inhibitors

Details for Australian Patent Application No. 2005312137 (hide)

Owner Merck Patent GmbH

Inventors Noelle Denualt, Marie; Lardy, Claude; Yvon, Stephane; Descours, Denis; Lecomte, Marc; Vidal, Catherine; Convard, Thierry

Agent Davies Collison Cave

Pub. Number AU-B-2005312137

PCT Pub. Number WO2006/058592

Priority 0412765 01.12.04 FR

Filing date 2 November 2005

Wipo publication date 8 June 2006

Acceptance publication date 26 May 2011

International Classifications

C07C 57/38 (2006.01) Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/50 (2006.01) - Pyridazines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/058592 Priority application(s): WO2006/058592

26 May 2011 Application Accepted

  Published as AU-B-2005312137

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005312142-Tetrahydropyrane derivatives for use as antidiabetics

2005312130-Plastic hollow body, especially plastic tube